Evidence map›Paper›PMID 27451288›Full record

ArticleTrends in microbiology2016

Bap: A New Type of Functional Amyloid.

Patrick Di Martino

Abstract readComment
PubMed Publisher
In one paragraph

Article in Trends in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Natural compounds in the fight againstFrontiers in pharmacology · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Patrick Di MartinoLaboratoire ERRMECe-EA1391, Université de Cergy-Pontoise, 5 mail Gay-Lussac CS 20601 Neuville, 95031 Cergy-Pontoise cedex, France. Electronic address: Patrick.di-martino@u-cergy.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria can build a biofilm matrix scaffold from exopolysaccharides or proteins, and DNA. In a recent report, Taglialegna and colleagues show that pathogenic Staphylococcus aureus produces a protein scaffold based on amyloid assembly of fragments from the biofilm-associated protein. Amyloidogenesis occurs in response to environmental signals.

Indexed as

AmyloidBacterial ProteinsBiofilmsStaphylococcal InfectionsStaphylococcus aureusAmyloidBacterial Proteinsaggregation.amyloidBapbiofilmmatrixStaphylococcus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.